Respiri Limited

Equities

RSH

AU000000RSH4

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 08:55:53 2024-06-02 pm EDT			5-day change	1st Jan Change
0.027 ^AUD	-3.57%		-10.00%	-10.00%

May. 09	Transcript : Respiri Limited - Special Call
Apr. 30	Respiri to Raise AU$1.6 Million via Placement	MT

Respiri Limited Announces Executive Changes

October 29, 2019 at 03:09 am EDT

Respiri Limited announced that the departure of its previous CEO, Mr. Mario Gattino has now been finalised. The company secretary, Alastair Beard will step into the role as interim CEO. Mr. Gattino will remain on the board as a non-executive director.

Latest news about Respiri Limited

Transcript : Respiri Limited - Special Call	May. 08
Respiri to Raise AU$1.6 Million via Placement	Apr. 30	MT
Respiri Partners with Hawaii Independent Physician Association for Remote Patient Monitoring Program; Shares Up 3%	Apr. 28	MT
Transcript : Respiri Limited - Shareholder/Analyst Call	Apr. 17
Respiri Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28	CI
Respiri Limited Announces Executive Changes	Jan. 28	CI
Respiri Signs Deal to Integrate Echo IQ’s Cardiovascular Technology to Remote Monitoring System; Shares Fall 4%	Jan. 24	MT
Respiri Limited Appoints Tom Takubo as Non-Executive Director	Dec. 13	CI
Transcript : Respiri Limited - Shareholder/Analyst Call	Nov. 14
Respiri Limited Announces Resignation of Brian Leedman as Non-Executive Director	Nov. 03	CI
Respiri Limited Secures Two Additional Healthcare Provider Contract	23-09-28	CI
Australian Bourse Halts Trading in Respiri’s Securities	23-09-14	MT
Respiri Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
Transcript : Respiri Limited - Special Call	23-08-30
Respiri Completes Access Manages Services Acquisition	23-08-14	MT
Respiri Completes AU$3 Million Share Purchase Plan	23-08-08	MT
Transcript : Respiri Limited - Shareholder/Analyst Call	23-08-07
Respiri Extends Closing Date of Share Purchase Plan	23-07-25	MT
Respiri Signs Marketing Agreement for Wheezo Device with Fi-Med Management	23-07-10	MT
Transcript : Access Managed Services LLC, Respiri Limited - M&A Call	23-06-06
Respiri Limited Appoints Brian Leedman as Non-Executive Director	23-05-23	CI
Respiri Appoints Chief Commercial Officer for US Market	23-04-12	MT
Respiri Limited Appoints William Sigsbee as Chief Commercial Officer for the US Market	23-04-11	CI
Transcript : Respiri Limited - Special Call	23-03-27
Respiri Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-27	CI

Chart Respiri Limited

Duration

Period

More charts

Company Profile

Respiri Limited is an Australia-based e-health software-as-a-service (SaaS) company that supports respiratory health management and remote patient monitoring (RPM). It is engaged in research, development and commercialization of medical devices, and the development of mobile health applications. Its Wheezo technology is a breath sensor (medical device) that works with the respiri mobile applications (patient user interface) to record and track wheeze. Wheezo is a smart device to help improve asthma management by monitoring wheeze and documenting symptoms, signs, triggers, weather conditions and medication use. The asthma management platform also facilitates the sharing of data with caregivers, physicians and other health care professionals. The Wheezo is also used to detect and record abnormal breath sounds (continuous adventitious breath sounds) in the windpipe (trachea), reported as WheezeRate in adults and children (two years and older).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-27 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
RESPIRI LIMITED	-10.00%	19.7M
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.41%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.6B

Other Advanced Medical Equipment & Technology